CORRECTIONS

Finding breast cancer early, Jan. 6, Business Report, D1

The story misstated the status and purpose of a business partnership involving biotech company Grail and what is known about the steps it is taking in a regulatory process. Grail is seeking to work with another entity to market in Hong Kong a test to detect cancer. Grail declined to say what regulatory approvals it is seeking for its tests in the U.S.